Idiopathic intracranial hypertension: A metabolic perspective using NMR spectroscopy

Key Points

• Findings indicate significant metabolic changes in patients with idiopathic intracranial hypertension.
• Key evidence shows alterations in cerebrospinal fluid metabolites that may serve as biomarkers.
• Analysis utilizing NMR spectroscopy uncovers details about metabolic pathways affected in the condition.
• Highlights the need for further exploration of metabolic interventions for managing idiopathic intracranial hypertension.